Dupilumab

ATC D11AH05 · 10 markets · 38 records

Dupilumab 10 markets · 38 records Forms

AU 9 records · 5 strengths

  • 300 mg/2 mLinjectionDupixent also in US·GB·SG
  • 200 mg/1.14 mLinjectionDupixent also in US·GB·SG
  • 175 mg/mLinjectionDUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled penDUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield unknown
  • 150 mg/mLinjectionDUPIXENT dupilumab (rch) 300 mg/2 mL solution for injection pre-filled syringe with needle shieldDUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled pen unknown

Records without a stated strength · 1 Dupixent

US 4 records · 2 strengths

GB 4 records · 2 strengths

CA 4 records · 2 strengths

SG 4 records · 3 strengths

Records without a stated strength · 1 DUPIXENT SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 200 mg/1.14ml

ES 4 records · 2 strengths

HK 4 records · 1 strengths

    Records without a stated strength · 1 DUPIXENT SOLUTION FOR INJECTION IN PRE-FILLED PEN 200MG/1.14ML、DUPIXENT SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 200MG/1.14ML (WITH NEEDLE SHIELD)

    TW 2 records · 2 strengths

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      Records without a stated strength · 1 Dupixent

      Side-by-side table

      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.